Marshall Wace’s Nanobiotix NBTX Stock Holding History

Marshall Wace’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$379K	Buy	10,044 +805	+9%	+$29.9K	﹤0.01%	2620
2026 Q1	$285K	Sell	9,239 -261	-3%	-$6.88K	﹤0.01%	2665
2025 Q4	$220K	Buy	+9,500	New	+$208K	﹤0.01%	2562

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Marshall Wace's NBTX Position: Q2 2026 in Review

Marshall Wace increased its Nanobiotix (NBTX) stake by 8.7% in Q2 2026, buying an estimated $29.9K and bringing the position to 10,044 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

Marshall Wace first reported a position in NBTX in Q4 2025 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

Marshall Wace held 10,044 shares of Nanobiotix worth $379K as of Q2 2026.
Marshall Wace bought 805 Nanobiotix shares in Q2 2026, an estimated $29.9K.
Nanobiotix made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2620 holding.
Marshall Wace first reported a position in Nanobiotix in Q4 2025 and has held it in 3 quarters since.
19 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.